Brief: Femasys Achieves Australian & New Zealand Regulatory Approvals For Femaseed For First-Line Infertility Treatment And Femvue Diagnostic
01/07/2025 14:15
Femasys Inc FEMY.O: FEMASYS: ACHIEVES AUSTRALIAN & NEW ZEALAND REGULATORY APPROVALS FOR FEMASEED FOR FIRST-LINE INFERTILITY TREATMENT AND FEMVUE DIAGNOSTIC Source text: ID:nGNX8WhcQT Further company coverage: FEMY.O
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview